Effects of nitric oxide donors on vascular endothelial growth factor gene induction

Biochemical and Biophysical Research Communications

Volumn 296, Issue 4, 2002, Pages 976-982

  Kimura, Hideo ^a   Ogura, Tsutomu ^b   Kurashima, Yukiko ^b   Weisz, Alessandro ^c   Esumi, Hiroyasu ^b  

^a GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Diazeniumdiolate; Hypoxia; Hypoxia inducible factor 1; Nitric oxide donor; Nitrosothiol; Redox; Sodium nitroprusside; Vascular endothelial growth factor

Indexed keywords

3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; ETHYL 2' (HYDROXYIMINO) 5 NITRO 3 HEXENECARBAMOYLPYRIDINE; GLUTATHIONE DERIVATIVE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LINSIDOMINE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; GENE ACTIVITY; GENE INDUCTION; HUMAN; PRIORITY JOURNAL; REPORTER GENE;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL NUCLEUS; DITHIOTHREITOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL GROWTH FACTORS; GENES, REPORTER; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LUCIFERASES; LYMPHOKINES; MOLSIDOMINE; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRITES; NITROPRUSSIDE; OXIDATION-REDUCTION; PENICILLAMINE; PLASMIDS; PROMOTER REGIONS (GENETICS); PYRIDINES; REDUCING AGENTS; RNA; RNA, MESSENGER; S-NITROSOGLUTATHIONE; TRANSCRIPTION FACTORS; TRIAZENES; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036382929     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02029-6     Document Type: Article

References (32)

1. L.J. Ignarro, Physiology and pathophysiology of nitric oxide, Kidney Int. Suppl. 55 (1996) S2-5.
2. H.H. Schmidt, U. Walter, NO at work, Cell 78 (1994) 919-925.
3. Y.C. Hou, A. Janczuk, P.G. Wang, Current trends in the development of nitric oxide donors, Curr. Pharm. Des. 5 (1999) 417-441.
4. M. Feelisch, The use of nitric oxide donors in pharmacological studies, Naunyn Schmiedebergs Arch. Pharmacol. 358 (1998) 113-122.
5. K.D. Kroncke, K. Fehsel, V. Kolb-Bachofen, Nitric oxide: cytotoxicity versus cytoprotection-how, why, when, and where? Nitric Oxide 1 (1997) 107-120.
6. D.A. Wink, J.B. Mitchell, Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide, Free Radic. Biol. Med. 25 (1998) 434-456.
7. N. Ferrara, T. Davis-Smyth, The biology of vascular endothelial growth factor, Endocr. Rev. 18 (1997) 4-25.
8. M. Klagsbrun, P.A. D'Amore, Vascular endothelial growth factor and its receptors, Cytokine Growth Factor Rev. 7 (1996) 259-270.
9. A. Jozkowicz, J.P. Cooke, I. Guevara, I. Huk, P. Funovics, O. Pachinger, F. Weidinger, J. Dulak, Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF, Cardiovasc. Res. 51 (2001) 773-783.
10. L.E. Huang, W.G. Willmore, J. Gu, M.A. Goldberg, H.F. Bunn, Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. Implications for oxygen sensing and signaling, J. Biol. Chem. 274 (1999) 9038-9044.
11. K. Sogawa, K. Numayama-Tsuruta, M. Ema, M. Abe, H. Abe, Y. Fujii-Kuriyama, Inhibition of hypoxia-inducible factor 1 activity by nitric oxide donors in hypoxia, Proc. Natl. Acad. Sci. USA 95 (1998) 7368-7373.
12. Y. Liu, H. Christou, T. Morita, E. Laughner, G.L. Semenza, S. Kourembanas, Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5′ enhancer, J. Biol. Chem. 273 (1998) 15257-15262.
13. H. Kimura, A. Weisz, Y. Kurashima, K. Hashimoto, T. Ogura, F. D'Acquisto, R. Addeo, M. Makuuchi, H. Esumi, Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide, Blood 95 (2000) 189-197.
14. L.A. Palmer, B. Gaston, R.A. Johns, Normoxic stabilization of hypoxia-inducible factor-1 expression and activity: redox-dependent effect of nitrogen oxides, Mol. Pharmacol. 58 (2000) 1197-1203.
15. K.B. Sandau, J. Fandrey, B. Brune, Accumulation of HIF-1α under the influence of nitric oxide, Blood 97 (2001) 1009-1015.
16. A. Minchenko, S. Salceda, T. Bauer, J. Caro, Hypoxia regulatory elements of the human vascular endothelial growth factor gene, Cell. Mol. Biol. Res. 40 (1994) 35-39.
17. K. Chin, Y. Kurashima, T. Ogura, H. Tajiri, S. Yoshida, H. Esumi, Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells, Oncogene 15 (1997) 437-442.
18. L.K. Keefer, R.W. Nims, K.M. Davies, D.A. Wink, "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms, Methods Enzymol. 268 (1996) 281-293.
19. S. Fukuyama, Y. Hirasawa, Y. Kato, M. Nishio, M. Ohno, S. Nishino, K. Maeda, M. Kato, Y. Kita, Structure-activity relationships of spontaneous nitric oxide releasers, FK409, and its derivatives, J. Pharmacol. Exp. Ther. 282 (1997) 236-242.
20. A.L. Fitzhugh, L.K. Keefer, Diazeniumdiolates: pro- and antioxidant applications of the "NONOates", Free Radic. Biol. Med. 28 (2000) 1463-1469.
21. M.N. Hughes, Relationships between nitric oxide, nitroxyl ion, nitrosonium cation, and peroxynitrite, Biochim. Biophys. Acta 1411 (1999) 263-272.
22. F. Murad, S. Waldman, C. Molina, B. Bennett, D. Leitman, Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation, Prog. Clin. Biol. Res. 249 (1987) 65-76.
23. T. Akaike, M. Yoshida, Y. Miyamoto, K. Sato, M. Kohno, K. Sasamoto, K. Miyazaki, S. Ueda, H. Maeda, Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/·NO through a radical reaction, Biochemistry 32 (1993) 827-832.
24. M. Kelm, Nitric oxide metabolism and breakdown, Biochim. Biophys. Acta 1411 (1999) 273-289.
25. A.R. Butler, C. Glidewell, J. McGinnis, W.I. Bisset, Further investigations regarding the toxicity of sodium nitroprusside, Clin. Chem. 33 (1987) 490-492.
26. P. Rauhala, A. Khaldi, K.P. Mohanakumar, C.C. Chiueh, Apparent role of hydroxyl radicals in oxidative brain injury induced by sodium nitroprusside, Free Radic. Biol. Med. 24 (1998) 1065-1073.
27. V. Ankoma-Sey, Y. Wang, Z. Dai, Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells, Hepatology 31 (2000) 141-148.
28. J. Dulak, A. Jozkowicz, A. Dembinska-Kiec, I. Guevara, A. Zdzienicka, D. Zmudzinska-Grochot, I. Florek, A. Wojtowicz, A. Szuba, J.P. Cooke, Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells, Arterioscler Thromb. Vasc. Biol. 20 (2000) 659-666.
29. M.A. Holland, L.M. Kozlowski, Clinical features and management of cyanide poisoning, Clin. Pharmacol. 5 (1986) 737-741.
30. D.N. Ramakrishna Rao, A.I. Cederbaum, Generation of reactive oxygen species by the redox cycling of nitroprusside, Biochim. Biophys. Acta 1289 (1996) 195-202.
31. B. Brune, A. von Knethen, K.B. Sandau, Transcription factors p53 and HIF-1α as targets of nitric oxide, Cell. Signal. 13 (2001) 525-533.
32. I. Ioannidis, M. Batz, T. Paul, H.G. Korth, R. Sustmann, H. De Groot, Enhanced release of nitric oxide causes increased cytotoxicity of S-nitroso-N-acetyl-DL-penicillamine and sodium nitroprusside under hypoxic conditions, Biochem. J. 318 (1996) 789-795.